Variant report

Variant	rs3774752
Chromosome Location	chr3:50209612-50209613
allele	C/T
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	EP300	chr3:50208804-50209676	HepG2	liver:	n/a	chr3:50209111-50209121 chr3:50209587-50209603
2	MAX	chr3:50208875-50209870	HepG2	liver:	n/a	chr3:50209651-50209667 chr3:50209660-50209670
3	ZEB1	chr3:50208098-50209914	HepG2	liver:	n/a	chr3:50209188-50209199 chr3:50209187-50209199 chr3:50209198-50209210
4	TCF7L2	chr3:50208942-50209717	PANC-1	pancreas:	n/a	chr3:50209281-50209290 chr3:50209278-50209294 chr3:50209279-50209293 chr3:50209278-50209294 chr3:50209282-50209292
5	JUND	chr3:50209101-50209762	HepG2	liver:	n/a	n/a
6	RCOR1	chr3:50208965-50209642	HepG2	liver:	n/a	n/a
7	NFIC	chr3:50208883-50209759	HepG2	liver:	n/a	n/a
8	TCF7L2	chr3:50208888-50209737	HepG2	liver:	n/a	chr3:50209281-50209290 chr3:50209278-50209294 chr3:50209279-50209293 chr3:50209278-50209294 chr3:50209282-50209292
9	NR2F2	chr3:50208872-50209684	HepG2	liver:	n/a	n/a
10	MAX	chr3:50208988-50209787	HepG2	liver:	n/a	chr3:50209651-50209667 chr3:50209660-50209670
11	HNF4A	chr3:50209056-50209624	HepG2	liver:	n/a	chr3:50209311-50209333 chr3:50209450-50209472 chr3:50209277-50209292
12	TCF7L2	chr3:50208843-50209771	Hela-S3	cervix:	n/a	chr3:50209281-50209290 chr3:50209278-50209294 chr3:50209279-50209293 chr3:50209278-50209294 chr3:50209282-50209292
13	YY1	chr3:50208973-50209664	HepG2	liver:	n/a	n/a
14	MAX	chr3:50209576-50209790	NB4	blood:	n/a	chr3:50209651-50209667 chr3:50209660-50209670
15	TEAD4	chr3:50208898-50209620	HepG2	liver:	n/a	n/a
16	POLR2A	chr3:50209572-50209623	H1-hESC	embryonic stem cell:	n/a	n/a
17	HDAC2	chr3:50208889-50209661	HepG2	liver:	n/a	chr3:50209111-50209120
18	POLR2A	chr3:50209543-50209718	Hela-S3	cervix:	n/a	n/a
19	RXRA	chr3:50208807-50209632	HepG2	liver:	n/a	chr3:50209320-50209329 chr3:50209323-50209334 chr3:50209465-50209479 chr3:50209322-50209335 chr3:50209322-50209335
20	ZEB1	chr3:50208871-50209625	HepG2	liver:	n/a	chr3:50209188-50209199 chr3:50209187-50209199 chr3:50209198-50209210
21	TCF7L2	chr3:50208973-50209670	HCT-116	colon:	n/a	chr3:50209281-50209290 chr3:50209278-50209294 chr3:50209279-50209293 chr3:50209278-50209294 chr3:50209282-50209292
22	MYC	chr3:50209586-50209644	HUVEC	blood vessel:	n/a	n/a

No.	Distal block	Cell Line	Cell type
1	chr3:50194586..50199661-chr3:50206741..50210376,5	K562	blood:
2	chr3:50164983..50167115-chr3:50208238..50210374,2	MCF-7	breast:
3	chr3:50191401..50200098-chr3:50206213..50213809,14	MCF-7	breast:
4	chr3:50208138..50210089-chr3:50211604..50213556,2	MCF-7	breast:

Variant related genes	Relation type
SEMA3F	TF binding region
MIR566	TF binding region
ENSG00000235016	Chromatin interaction
ENSG00000001617	Chromatin interaction

Extended variants
information (count: 125 )
Associated
traits (count: 0)

rSNPs within LD-proxies of this variant (count:97)

rs_ID	r²[population]
rs1005678	0.90[CHB][hapmap];0.91[JPT][hapmap];0.92[ASN][1000 genomes]
rs11130248	0.90[CHB][hapmap];0.91[CHD][hapmap];1.00[GIH][hapmap];0.82[JPT][hapmap];0.85[AMR][1000 genomes];0.82[EUR][1000 genomes]
rs12054052	1.00[AFR][1000 genomes];0.97[AMR][1000 genomes];1.00[EUR][1000 genomes];0.93[ASN][1000 genomes]
rs12054403	0.90[CHB][hapmap];0.91[CHD][hapmap];1.00[GIH][hapmap];0.82[JPT][hapmap];0.85[AMR][1000 genomes];0.82[EUR][1000 genomes]
rs12485286	0.81[AMR][1000 genomes];0.82[EUR][1000 genomes]
rs12485390	0.90[CHB][hapmap];1.00[AFR][1000 genomes];0.95[AMR][1000 genomes];0.82[EUR][1000 genomes]
rs12485909	0.90[CHB][hapmap];0.93[CHD][hapmap];1.00[GIH][hapmap];0.82[JPT][hapmap];1.00[AFR][1000 genomes];0.97[AMR][1000 genomes];0.82[EUR][1000 genomes];0.91[ASN][1000 genomes]
rs12487392	1.00[AFR][1000 genomes];1.00[AMR][1000 genomes];0.91[ASN][1000 genomes]
rs12488235	0.91[AMR][1000 genomes]
rs12488302	0.90[CHB][hapmap];0.91[CHD][hapmap];1.00[GIH][hapmap];0.82[JPT][hapmap];1.00[AFR][1000 genomes];0.94[AMR][1000 genomes];0.82[EUR][1000 genomes]
rs12490809	1.00[AFR][1000 genomes];0.85[AMR][1000 genomes];0.82[EUR][1000 genomes]
rs12490837	0.82[EUR][1000 genomes]
rs12491177	1.00[AFR][1000 genomes];0.83[AMR][1000 genomes];0.92[EUR][1000 genomes];0.88[ASN][1000 genomes]
rs12492683	1.00[AFR][1000 genomes];0.91[AMR][1000 genomes];0.82[EUR][1000 genomes]
rs12492880	0.86[CHB][hapmap];0.91[CHD][hapmap];1.00[GIH][hapmap];0.82[JPT][hapmap];0.94[AMR][1000 genomes]
rs12493693	0.92[AMR][1000 genomes];0.82[EUR][1000 genomes]
rs12494414	0.85[CHB][hapmap];0.85[CHD][hapmap];1.00[AFR][1000 genomes];0.92[AMR][1000 genomes];0.82[EUR][1000 genomes]
rs12495261	0.85[AMR][1000 genomes];0.82[EUR][1000 genomes]
rs12496815	1.00[AFR][1000 genomes];0.85[AMR][1000 genomes];0.82[EUR][1000 genomes]
rs12497018	1.00[AFR][1000 genomes]
rs12498048	1.00[AFR][1000 genomes];0.95[AMR][1000 genomes];0.81[ASN][1000 genomes]
rs12632110	0.90[CHB][hapmap];0.93[CHD][hapmap];0.95[JPT][hapmap];0.94[ASN][1000 genomes]
rs12721544	1.00[AFR][1000 genomes];1.00[AMR][1000 genomes];0.82[EUR][1000 genomes];0.93[ASN][1000 genomes]
rs2006199	0.86[CHB][hapmap];0.86[CHD][hapmap];1.00[GIH][hapmap];1.00[AFR][1000 genomes];0.94[AMR][1000 genomes];0.82[EUR][1000 genomes]
rs2021734	0.94[AMR][1000 genomes];0.84[EUR][1000 genomes];0.94[ASN][1000 genomes]
rs2071203	0.90[CHB][hapmap];0.91[CHD][hapmap];1.00[GIH][hapmap];0.82[JPT][hapmap];0.88[AMR][1000 genomes];0.82[EUR][1000 genomes]
rs2071204	0.90[CHB][hapmap];0.91[CHD][hapmap];1.00[GIH][hapmap];0.82[JPT][hapmap];0.88[AMR][1000 genomes];0.82[EUR][1000 genomes]
rs2071205	0.88[AMR][1000 genomes];0.82[EUR][1000 genomes]
rs2071801	1.00[AFR][1000 genomes];0.85[AMR][1000 genomes];0.82[EUR][1000 genomes]
rs2071804	0.80[CHB][hapmap];0.82[EUR][1000 genomes]
rs2072053	1.00[AFR][1000 genomes];0.98[AMR][1000 genomes];1.00[EUR][1000 genomes];0.96[ASN][1000 genomes]
rs2072054	0.90[CHB][hapmap];0.93[CHD][hapmap];1.00[GIH][hapmap];0.91[JPT][hapmap];0.95[AMR][1000 genomes];1.00[EUR][1000 genomes];0.93[ASN][1000 genomes]
rs2073497	0.82[AMR][1000 genomes];0.82[EUR][1000 genomes]
rs2073500	0.90[CHB][hapmap];0.91[CHD][hapmap];1.00[GIH][hapmap];0.82[JPT][hapmap];1.00[AFR][1000 genomes];0.85[AMR][1000 genomes];0.82[EUR][1000 genomes]
rs2229647	0.90[AMR][1000 genomes];0.82[EUR][1000 genomes]
rs2233476	0.90[CHB][hapmap];0.91[CHD][hapmap];1.00[GIH][hapmap];0.82[JPT][hapmap];0.81[AMR][1000 genomes];0.82[EUR][1000 genomes]
rs2236940	0.90[CHB][hapmap];0.90[CHD][hapmap];0.82[JPT][hapmap];0.83[ASN][1000 genomes]
rs2236941	0.90[CHB][hapmap];0.90[CHD][hapmap];0.82[JPT][hapmap];0.82[ASN][1000 genomes]
rs2236943	1.00[AFR][1000 genomes];0.95[AMR][1000 genomes];0.82[EUR][1000 genomes];0.81[ASN][1000 genomes]
rs2236944	0.90[CHB][hapmap];0.91[CHD][hapmap];0.82[JPT][hapmap];0.80[ASN][1000 genomes]
rs2236946	0.90[CHB][hapmap];0.91[CHD][hapmap];1.00[GIH][hapmap];0.81[JPT][hapmap];0.82[AMR][1000 genomes];0.82[EUR][1000 genomes]
rs2236949	1.00[AFR][1000 genomes];0.85[AMR][1000 genomes]
rs2269430	0.90[CHB][hapmap];1.00[AFR][1000 genomes];0.95[AMR][1000 genomes];0.82[EUR][1000 genomes]
rs2269432	0.90[CHB][hapmap];0.82[JPT][hapmap];0.88[AMR][1000 genomes];0.82[EUR][1000 genomes]
rs2269568	0.85[AMR][1000 genomes];0.82[EUR][1000 genomes]
rs2282750	1.00[AFR][1000 genomes];0.95[AMR][1000 genomes];0.82[EUR][1000 genomes];0.83[ASN][1000 genomes]
rs2285043	0.90[CHB][hapmap];0.91[CHD][hapmap];1.00[GIH][hapmap];0.82[JPT][hapmap];0.87[AMR][1000 genomes];0.82[EUR][1000 genomes]
rs2285044	0.90[CHB][hapmap];0.82[JPT][hapmap];0.88[AMR][1000 genomes];0.82[EUR][1000 genomes]
rs2298953	0.90[CHB][hapmap];0.93[CHD][hapmap];0.81[JPT][hapmap];0.81[ASN][1000 genomes]
rs2298954	0.90[CHB][hapmap];0.93[CHD][hapmap];0.82[JPT][hapmap];0.81[ASN][1000 genomes]
rs2624838	0.95[ASN][1000 genomes]
rs2624839	0.81[CHB][hapmap];0.93[CHD][hapmap];0.91[JPT][hapmap];0.89[ASN][1000 genomes]
rs3213621	0.90[CHB][hapmap];0.91[CHD][hapmap];1.00[GIH][hapmap];0.82[JPT][hapmap];0.82[EUR][1000 genomes]
rs35455589	0.90[CHB][hapmap];0.88[CHD][hapmap];1.00[GIH][hapmap];0.82[JPT][hapmap];0.85[AMR][1000 genomes];0.82[EUR][1000 genomes]
rs35587949	0.90[CHB][hapmap];0.91[CHD][hapmap];1.00[GIH][hapmap];0.82[AMR][1000 genomes];0.82[EUR][1000 genomes]
rs3774736	0.92[AMR][1000 genomes];1.00[EUR][1000 genomes]
rs3774739	0.95[CHB][hapmap];1.00[CHD][hapmap];1.00[GIH][hapmap];1.00[JPT][hapmap];1.00[AFR][1000 genomes];1.00[AMR][1000 genomes];1.00[EUR][1000 genomes];0.98[ASN][1000 genomes]
rs3774741	1.00[AFR][1000 genomes];1.00[AMR][1000 genomes];1.00[EUR][1000 genomes];0.96[ASN][1000 genomes]
rs3774748	1.00[AFR][1000 genomes];1.00[AMR][1000 genomes];0.92[EUR][1000 genomes];0.99[ASN][1000 genomes]
rs3774753	0.90[CHB][hapmap];0.88[CHD][hapmap];0.82[JPT][hapmap]
rs3774754	1.00[AFR][1000 genomes];0.88[AMR][1000 genomes];0.82[EUR][1000 genomes]
rs3774755	0.90[CHB][hapmap];0.88[CHD][hapmap];1.00[GIH][hapmap];0.82[JPT][hapmap];1.00[AFR][1000 genomes];0.85[AMR][1000 genomes];0.82[EUR][1000 genomes]
rs4141407	0.90[CHB][hapmap];0.82[JPT][hapmap];0.91[AMR][1000 genomes];0.82[EUR][1000 genomes];0.83[ASN][1000 genomes]
rs4688679	0.90[CHB][hapmap];1.00[GIH][hapmap];0.81[JPT][hapmap];0.81[AMR][1000 genomes];0.82[EUR][1000 genomes]
rs4688682	0.90[CHB][hapmap];0.93[CHD][hapmap];1.00[GIH][hapmap];1.00[AFR][1000 genomes];0.95[AMR][1000 genomes];0.82[EUR][1000 genomes];0.80[ASN][1000 genomes]
rs4688683	0.86[AMR][1000 genomes];0.88[ASN][1000 genomes]
rs4688722	1.00[AFR][1000 genomes]
rs4688724	0.90[CHB][hapmap];0.82[JPT][hapmap];1.00[AFR][1000 genomes];0.85[AMR][1000 genomes];0.82[EUR][1000 genomes]
rs4688725	0.82[EUR][1000 genomes]
rs4688728	0.84[AMR][1000 genomes];0.82[EUR][1000 genomes]
rs4688732	0.90[CHB][hapmap];0.91[CHD][hapmap];1.00[GIH][hapmap];0.82[JPT][hapmap];1.00[AFR][1000 genomes];0.88[AMR][1000 genomes];0.82[EUR][1000 genomes]
rs4688733	0.82[EUR][1000 genomes]
rs4688734	0.90[CHB][hapmap];0.90[CHD][hapmap];1.00[GIH][hapmap];0.81[JPT][hapmap];0.88[AMR][1000 genomes];0.82[EUR][1000 genomes]
rs4688736	0.88[AMR][1000 genomes];0.82[EUR][1000 genomes]
rs4688738	1.00[AFR][1000 genomes];0.89[AMR][1000 genomes]
rs4688741	0.90[CHB][hapmap];0.93[CHD][hapmap];1.00[GIH][hapmap];0.82[JPT][hapmap];1.00[AFR][1000 genomes];0.95[AMR][1000 genomes];0.82[EUR][1000 genomes];0.81[ASN][1000 genomes]
rs4688742	0.95[AMR][1000 genomes];0.82[EUR][1000 genomes];0.81[ASN][1000 genomes]
rs4688743	0.89[AMR][1000 genomes]
rs4688744	1.00[AFR][1000 genomes];0.92[AMR][1000 genomes];0.82[EUR][1000 genomes];0.83[ASN][1000 genomes]
rs4688746	0.94[JPT][hapmap];1.00[AFR][1000 genomes];1.00[AMR][1000 genomes];0.82[EUR][1000 genomes];0.94[ASN][1000 genomes]
rs4688747	1.00[AFR][1000 genomes];1.00[AMR][1000 genomes];1.00[EUR][1000 genomes];0.96[ASN][1000 genomes]
rs57944420	0.88[AMR][1000 genomes];0.82[EUR][1000 genomes]
rs57978992	0.95[AMR][1000 genomes];0.82[EUR][1000 genomes]
rs58137261	1.00[AFR][1000 genomes];0.97[AMR][1000 genomes];1.00[EUR][1000 genomes];0.92[ASN][1000 genomes]
rs58181992	0.82[EUR][1000 genomes]
rs58191283	1.00[AFR][1000 genomes];0.97[AMR][1000 genomes];1.00[EUR][1000 genomes];0.91[ASN][1000 genomes]
rs58648044	0.83[ASN][1000 genomes]
rs60276643	1.00[AFR][1000 genomes];1.00[AMR][1000 genomes];0.82[EUR][1000 genomes];0.90[ASN][1000 genomes]
rs72932959	0.88[AMR][1000 genomes];0.82[EUR][1000 genomes]
rs72932987	0.82[AMR][1000 genomes];0.82[EUR][1000 genomes]
rs7645537	0.90[CHB][hapmap];0.93[CHD][hapmap];1.00[GIH][hapmap];0.82[JPT][hapmap];0.92[AMR][1000 genomes];0.82[EUR][1000 genomes];0.81[ASN][1000 genomes]
rs9311449	0.83[AMR][1000 genomes];0.82[EUR][1000 genomes]
rs9681992	0.84[AMR][1000 genomes]
rs9830408	0.90[CHB][hapmap];0.82[JPT][hapmap]
rs9852677	0.85[CHD][hapmap]
rs9882618	0.94[AMR][1000 genomes];0.82[EUR][1000 genomes];0.90[ASN][1000 genomes]
rs9883222	0.90[CHB][hapmap];0.93[CHD][hapmap]

Variant overlapped rSNPs/rCNVs (count:28 , 50 per page) page: 1

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	nsv834690	chr3:50101835-50267584	Strong transcription Weak transcription Flanking Active TSS Active TSS Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh Genic enhancers Transcr. at gene 5' and 3' Bivalent/Poised TSS ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	24 gene(s)	inside rSNPs	diseases
2	nsv515986	chr3:50104307-50267584	Bivalent Enhancer Strong transcription Weak transcription Flanking Bivalent TSS/Enh Active TSS Enhancers Genic enhancers Flanking Active TSS Transcr. at gene 5' and 3' Bivalent/Poised TSS ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	24 gene(s)	inside rSNPs	diseases
3	nsv432418	chr3:50114496-50224196	Bivalent Enhancer Transcr. at gene 5' and 3' Genic enhancers Weak transcription Strong transcription Flanking Active TSS Enhancers Active TSS Flanking Bivalent TSS/Enh Bivalent/Poised TSS ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	18 gene(s)	inside rSNPs	diseases
4	nsv1001775	chr3:50129479-50311666	Flanking Active TSS Active TSS Enhancers Bivalent Enhancer Strong transcription Weak transcription Transcr. at gene 5' and 3' Genic enhancers Flanking Bivalent TSS/Enh Bivalent/Poised TSS ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	42 gene(s)	inside rSNPs	diseases
5	nsv876768	chr3:50144951-50267584	Bivalent/Poised TSS Enhancers Flanking Active TSS Flanking Bivalent TSS/Enh Active TSS Weak transcription Bivalent Enhancer Strong transcription Genic enhancers Transcr. at gene 5' and 3' ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	17 gene(s)	inside rSNPs	diseases
6	nsv523662	chr3:50144951-50584999	Flanking Bivalent TSS/Enh Weak transcription Genic enhancers Bivalent Enhancer Strong transcription Transcr. at gene 5' and 3' Flanking Active TSS Enhancers Active TSS Bivalent/Poised TSS ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	101 gene(s)	inside rSNPs	diseases
7	nsv1013949	chr3:50151712-50339163	Flanking Active TSS Weak transcription Enhancers Transcr. at gene 5' and 3' Active TSS Bivalent Enhancer Genic enhancers Strong transcription Flanking Bivalent TSS/Enh ZNF genes & repeats Bivalent/Poised TSS	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	53 gene(s)	inside rSNPs	diseases
8	nsv590250	chr3:50153356-50332697	Weak transcription Enhancers Strong transcription Flanking Active TSS Genic enhancers Bivalent/Poised TSS Active TSS Bivalent Enhancer Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	43 gene(s)	inside rSNPs	diseases
9	nsv876769	chr3:50155468-50408398	Active TSS Enhancers Weak transcription Genic enhancers Flanking Active TSS Bivalent/Poised TSS Strong transcription Flanking Bivalent TSS/Enh Bivalent Enhancer Transcr. at gene 5' and 3' ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	94 gene(s)	inside rSNPs	diseases
10	esv1821728	chr3:50156142-50657253	Strong transcription Weak transcription Flanking Active TSS Active TSS Bivalent Enhancer Transcr. at gene 5' and 3' Enhancers Genic enhancers Bivalent/Poised TSS Flanking Bivalent TSS/Enh ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	109 gene(s)	inside rSNPs	diseases
11	esv1793751	chr3:50157364-50476363	Weak transcription Enhancers Transcr. at gene 5' and 3' Strong transcription Flanking Bivalent TSS/Enh Genic enhancers Flanking Active TSS Active TSS Bivalent Enhancer Bivalent/Poised TSS ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	98 gene(s)	inside rSNPs	diseases
12	esv1828162	chr3:50157364-50506151	Enhancers Genic enhancers Transcr. at gene 5' and 3' Flanking Active TSS Active TSS Weak transcription Strong transcription Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	98 gene(s)	inside rSNPs	diseases
13	nsv590251	chr3:50158774-50337422	Active TSS Strong transcription Flanking Active TSS Weak transcription Enhancers Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' Genic enhancers ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	53 gene(s)	inside rSNPs	diseases
14	nsv470561	chr3:50158774-50584999	Flanking Active TSS Enhancers Weak transcription Genic enhancers Active TSS Bivalent Enhancer Strong transcription Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' Bivalent/Poised TSS ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	99 gene(s)	inside rSNPs	diseases
15	nsv876770	chr3:50158774-50609624	Active TSS Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer Strong transcription Genic enhancers Transcr. at gene 5' and 3' Bivalent/Poised TSS ZNF genes & repeats Flanking Bivalent TSS/Enh	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	103 gene(s)	inside rSNPs	diseases
16	nsv523560	chr3:50172397-50339163	Active TSS Enhancers Weak transcription Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer Genic enhancers Strong transcription Transcr. at gene 5' and 3' Bivalent/Poised TSS ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	53 gene(s)	inside rSNPs	diseases
17	nsv460529	chr3:50178011-50324672	Enhancers Weak transcription Bivalent Enhancer Bivalent/Poised TSS Transcr. at gene 5' and 3' Genic enhancers Strong transcription Flanking Active TSS Active TSS Flanking Bivalent TSS/Enh ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	40 gene(s)	inside rSNPs	diseases
18	nsv460530	chr3:50178011-50324672	Bivalent Enhancer Weak transcription Flanking Active TSS Enhancers Strong transcription Active TSS Transcr. at gene 5' and 3' Genic enhancers Bivalent/Poised TSS Flanking Bivalent TSS/Enh ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	40 gene(s)	inside rSNPs	diseases
19	nsv590252	chr3:50178011-50324672	Enhancers Bivalent Enhancer Strong transcription Active TSS Flanking Active TSS Weak transcription Bivalent/Poised TSS Genic enhancers Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	40 gene(s)	inside rSNPs	diseases
20	nsv1002916	chr3:50187646-50311666	Enhancers Flanking Bivalent TSS/Enh Weak transcription Strong transcription Flanking Active TSS Genic enhancers Active TSS Bivalent Enhancer Transcr. at gene 5' and 3' Bivalent/Poised TSS ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	40 gene(s)	inside rSNPs	diseases
21	nsv536564	chr3:50187646-50311666	Flanking Active TSS Enhancers Weak transcription Strong transcription Flanking Bivalent TSS/Enh Bivalent/Poised TSS Active TSS Genic enhancers Bivalent Enhancer Transcr. at gene 5' and 3' ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	40 gene(s)	inside rSNPs	diseases
22	nsv1014256	chr3:50187646-50339163	Enhancers Active TSS Strong transcription Weak transcription Genic enhancers Bivalent/Poised TSS Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Transcr. at gene 5' and 3' ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	53 gene(s)	inside rSNPs	diseases
23	nsv536565	chr3:50187646-50339163	Flanking Active TSS Bivalent Enhancer Active TSS Strong transcription Enhancers Weak transcription Genic enhancers Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh Bivalent/Poised TSS ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	53 gene(s)	inside rSNPs	diseases
24	nsv1001993	chr3:50187646-50640808	Weak transcription Enhancers Flanking Active TSS Active TSS Genic enhancers Bivalent/Poised TSS Bivalent Enhancer Strong transcription Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	104 gene(s)	inside rSNPs	diseases
25	nsv590253	chr3:50196418-50337422	Flanking Active TSS Flanking Bivalent TSS/Enh Weak transcription Genic enhancers Transcr. at gene 5' and 3' Active TSS Enhancers Strong transcription Bivalent Enhancer Bivalent/Poised TSS ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	53 gene(s)	inside rSNPs	diseases
26	esv2757870	chr3:50198478-50371377	Genic enhancers Flanking Bivalent TSS/Enh Enhancers Bivalent Enhancer Active TSS Bivalent/Poised TSS Weak transcription Flanking Active TSS Transcr. at gene 5' and 3' Strong transcription ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	74 gene(s)	inside rSNPs	diseases
27	esv2759148	chr3:50198478-50371377	Enhancers Weak transcription Genic enhancers Active TSS Bivalent Enhancer Flanking Active TSS Flanking Bivalent TSS/Enh Strong transcription Bivalent/Poised TSS Transcr. at gene 5' and 3' ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	74 gene(s)	inside rSNPs	diseases
28	nsv834692	chr3:50198485-50393464	Enhancers Weak transcription Flanking Bivalent TSS/Enh Flanking Active TSS Genic enhancers Bivalent Enhancer Active TSS Transcr. at gene 5' and 3' Strong transcription Bivalent/Poised TSS ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	94 gene(s)	inside rSNPs	diseases

No data

Chromatin state (count:84 , 50 per page) page: 1 2

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr3:50195400-50210200	Genic enhancers	Fetal Stomach	stomach
2	chr3:50195400-50210600	Enhancers	Left Ventricle	heart
3	chr3:50195400-50210800	Enhancers	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
4	chr3:50196200-50211600	Enhancers	Rectal Mucosa Donor 31	rectum
5	chr3:50197200-50211600	Genic enhancers	Esophagus	oesophagus
6	chr3:50200000-50210400	Enhancers	Fetal Brain Male	brain
7	chr3:50200600-50211800	Enhancers	Right Ventricle	heart
8	chr3:50202000-50210600	Enhancers	A549	lung
9	chr3:50202200-50210400	Enhancers	Lung	lung
10	chr3:50202800-50211000	Enhancers	Fetal Muscle Leg	muscle
11	chr3:50203000-50210000	Enhancers	Duodenum Mucosa	Duodenum
12	chr3:50203400-50211400	Weak transcription	Placenta Amnion	Placenta Amnion
13	chr3:50203800-50210000	Genic enhancers	HMEC	breast
14	chr3:50204400-50211000	Weak transcription	H9 Cell Line	embryonic stem cell
15	chr3:50204600-50226600	Weak transcription	Brain Anterior Caudate	brain
16	chr3:50204800-50210400	Enhancers	Stomach Smooth Muscle	stomach
17	chr3:50204800-50210600	Genic enhancers	Foreskin Keratinocyte Primary Cells skin03	Skin
18	chr3:50204800-50211200	Weak transcription	Aorta	Aorta
19	chr3:50204800-50211800	Weak transcription	iPS-20b Cell Line	embryonic stem cell
20	chr3:50205000-50212800	Genic enhancers	Foreskin Keratinocyte Primary Cells skin02	Skin
21	chr3:50205400-50210200	Genic enhancers	NHEK	skin
22	chr3:50205400-50211800	Enhancers	Stomach Mucosa	stomach
23	chr3:50205400-50226600	Weak transcription	Brain Dorsolateral Prefrontal Cortex	brain
24	chr3:50205400-50226600	Weak transcription	Rectal Smooth Muscle	rectum
25	chr3:50205600-50211200	Weak transcription	HUES48 Cell Line	embryonic stem cell
26	chr3:50205600-50211400	Weak transcription	iPS-18 Cell Line	embryonic stem cell
27	chr3:50205800-50211800	Weak transcription	Fetal Kidney	kidney
28	chr3:50206400-50226600	Weak transcription	NHLF	lung
29	chr3:50206600-50211200	Weak transcription	Ovary	ovary
30	chr3:50206600-50211600	Genic enhancers	Breast Myoepithelial Primary Cells	Breast
31	chr3:50207200-50211600	Enhancers	Spleen	Spleen
32	chr3:50207600-50209800	Genic enhancers	ES-UCSF4 Cell Line	embryonic stem cell
33	chr3:50207600-50210200	Enhancers	Fetal Adrenal Gland	Adrenal Gland
34	chr3:50208200-50209800	Enhancers	Fetal Lung	lung
35	chr3:50208200-50210600	Enhancers	Fetal Heart	heart
36	chr3:50208200-50211200	Weak transcription	HUES64 Cell Line	embryonic stem cell
37	chr3:50208200-50211600	Genic enhancers	iPS DF 19.11 Cell Line	embryonic stem cell
38	chr3:50208400-50210600	Bivalent Enhancer	Foreskin Melanocyte Primary Cells skin01	Skin
39	chr3:50208400-50210600	Enhancers	Rectal Mucosa Donor 29	rectum
40	chr3:50208400-50211400	Enhancers	Colonic Mucosa	Colon
41	chr3:50208600-50210200	Enhancers	Duodenum Smooth Muscle	Duodenum
42	chr3:50208600-50210200	Genic enhancers	Fetal Brain Female	brain
43	chr3:50208600-50210200	Enhancers	Gastric	stomach
44	chr3:50208600-50210400	Enhancers	Muscle Satellite Cultured Cells	--
45	chr3:50208600-50210400	Enhancers	Psoas Muscle	Psoas
46	chr3:50208600-50211200	Weak transcription	iPS DF 6.9 Cell Line	embryonic stem cell
47	chr3:50208600-50211200	Weak transcription	Primary monocytes fromperipheralblood	blood
48	chr3:50208600-50211200	Enhancers	Fetal Muscle Trunk	muscle
49	chr3:50208600-50217000	Weak transcription	K562	blood
50	chr3:50208800-50210000	Weak transcription	Brain Cingulate Gyrus	brain

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links